Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.

NCT02017457 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia
Myelodysplastic Syndrome

Interventions

BIOLOGICAL: Donor lymphocyte infusion
DRUG: Azacytidine

Sponsor

Carlos Graux, MD, PhD

Collaborators

[object Object]
[object Object]